Health Sector ETFS

 
Health Sector ETFS top ^
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Gilead Sciences Inc , Amgen Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for xlv investment picks
  • Holdings: Procter & Gamble Co , Coca-Cola Co , Wal-Mart Stores Inc , Philip Morris International Inc , CVS Health Corp ,
  • Morningstar Rating: 3 Stars
Sign-up for xlp investment picks
  • Holdings: Consumer Staples Select Sector SPDR® ETF , Utilities Select Sector SPDR® ETF , Health Care Select Sector SPDR® ETF , Technology Select Sector SPDR® ETF , Consumer Discret Sel Sect SPDR® ETF ,
  • Morningstar Rating: 4 Stars
Sign-up for eql investment picks
  • Holdings: Health Care Select Sector SPDR® ETF , Health Care Select Sector , Health Care Select Sector , Health Care Select Sector , Health Care Select Sector ,
Sign-up for cure investment picks
  • Holdings: Goldman Finl Sq Trsry Ins , WisdomTree Japan Hedged Equity ETF , Health Care Select Sector SPDR® ETF , Technology Select Sector SPDR® ETF , Financial Select Sector SPDR® ETF ,
  • Morningstar Rating: 2 Stars
Sign-up for gtaa investment picks

 
News Articles for Health Sector ETFS top ^
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases, and Intrexon Corporation (NYSE:XON), a leader in synthetic biology, today announced plans to file an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) in the first half of 2015 for their drug candidate, GM-HDF-COL7 (genetically-modified human dermal fibroblast, collagen VII). The companies are developing this new cell-based therapeutic for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), the most severe form of the rare connective tissue disorder epidermolysis bullosa.
Sign-up for Fibrocell Science and Intrexon Advance GM-HDF-COL7 toward Clinical Development for the Treatment of Recessive Dystrophic Epidermolysis Bullosa investment picks
Companies to Develop Universal Donor Chondrocyte Cell Treatments WALTHAM, Mass.
Sign-up for Histogenics and Intrexon Announce Formation of Exclusive Channel Collaboration for Cartilage Repair Therapies investment picks
Companies to Utilize Intrexon's Novel Microbial-based Production Approach for a Target Active Pharmaceutical Ingredient SAN CARLOS, Calif.
Sign-up for Intrexon and Amneal Expand Relationship with Second Product Collaboration investment picks
ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, has named John T.
Sign-up for ICF International Names John T. Guda Senior Vice President investment picks
By Chelsey Dulaney Gentiva Health Services Inc. has agreed to be acquired by Kindred Healthcare Inc. for about $720 million in cash and stock after a nearly five-month-long pursuit that resulted in multiple rejected offers, the companies said Thursday.
Sign-up for Kindred to acquire Gentiva after five-month pursuit investment picks
http://media.marketwire.com/attachments/201403/72915_cannabistherapy.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153257&ProfileId=051205&sourceType=1 BOULDER, CO --
Sign-up for Cannabis Therapy Corp. Announces Revenue Milestone With Launch of Updated Canna-Pet(TM) Website investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025365-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/3/11G025365/Agrium_4clr_R_200dpi_(2)-4714422682.jpg CALGARY, AB--(Marketwired - November 05, 2014) - Agrium Inc. (TSX: AGU) (NYSE: AGU), through its subsidiary Loveland Products, Inc., and CH Biotech R&D Co., Ltd.
Sign-up for Agrium Agrees to Take Equity Stake in CH Biotech R&D investment picks
2014/12/2
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982060001&sourceType=1 http://media3.marketwire.com/logos/20120319-teluslogo200.jpg http://media3.marketwire.com/logos/20141201-db_Ang_200.jpg QUEBEC CITY, QUEBEC --
Sign-up for Survey: Vast Majority of Quebecers Want Their Health Service Providers to Join the Digital Age investment picks
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative Canada NewsWire LONDON and PITTSBURGH , Dec.
Sign-up for Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative investment picks
2014/10/7
RadNet, Inc. RDNT Sept.
Sign-up for UPDATE: Charting a bearish October technical -2- investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Health Sector ETFS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Health Science  |  Next: Health Sector Funds